Market closed

GlaxoSmithKline/£GSK

08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX

About GlaxoSmithKline

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Ticker

£GSK

Trading on

LSE

Industry

Pharmaceuticals

Employees

70,212

GlaxoSmithKline Metrics

BasicAdvanced
£54B
Market cap
21.75
P/E ratio
£0.61
EPS
0.33
Beta
£0.60
Dividend rate
4.54%
Dividend yield
£54B
0.33
£18.24
£12.83
8.6M
£0.60
0.806
0.516
98.446
119.371
95.58%
10.83%
7.24%
21.85%
21.747
1.719
3.85
-7.02
10.947
4.54%
5.59%
-58.92%
5.91%
-17.09%
-15.19%

What the Analysts think about GlaxoSmithKline

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for GlaxoSmithKline stock.

GlaxoSmithKline Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

GlaxoSmithKline Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe

Buy £GSK

£

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Jan
9
GlaxoSmithKline
Dividend·Payment
£0.15
Per share

FAQs

What’s the current market cap for GlaxoSmithKline stock?

GlaxoSmithKline (GSK) has a market cap of £54B as of December 21, 2024.

What is the P/E ratio for GlaxoSmithKline stock?

The price to earnings (P/E) ratio for GlaxoSmithKline (GSK) stock is 21.75 as of December 21, 2024.

Does GlaxoSmithKline stock pay dividends?

Yes, the GlaxoSmithKline (GSK) stock pays dividends to shareholders. As of December 21, 2024, the dividend rate is £0.6 and the yield is 4.54%. GlaxoSmithKline has a payout ratio of 95.58% on a trailing twelve-month basis.

When is the next GlaxoSmithKline dividend payment date?

The next GlaxoSmithKline (GSK) dividend payment is scheduled for January 09, 2025.

What is the beta indicator for GlaxoSmithKline?

GlaxoSmithKline (GSK) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.